Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Low nephron endowment increases susceptibility to renal stress and chronic kidney disease
Pamela I. Good, Ling Li, Holly A. Hurst, Ileana Serrano Herrera, Katherine Xu, Meenakshi Rao, David A. Bateman, Qais Al-Awqati, Vivette D. D’Agati, Frank Costantini, Fangming Lin
Pamela I. Good, Ling Li, Holly A. Hurst, Ileana Serrano Herrera, Katherine Xu, Meenakshi Rao, David A. Bateman, Qais Al-Awqati, Vivette D. D’Agati, Frank Costantini, Fangming Lin
View: Text | PDF
Research Article Nephrology

Low nephron endowment increases susceptibility to renal stress and chronic kidney disease

  • Text
  • PDF
Abstract

Preterm birth results in low nephron endowment and increased risk of acute kidney injury (AKI) and chronic kidney disease (CKD). To understand the pathogenesis of AKI and CKD in preterm humans, we generated potentially novel mouse models with a 30%–70% reduction in nephron number by inhibiting or deleting Ret tyrosine kinase in the developing ureteric bud. These mice developed glomerular and tubular hypertrophy, followed by the transition to CKD, recapitulating the renal pathological changes seen in humans born preterm. We injected neonatal mice with gentamicin, a ubiquitous nephrotoxic exposure in preterm infants, and detected more severe proximal tubular injury in mice with low nephron number compared with controls with normal nephron number. Mice with low nephron number had reduced proliferative repair with more rapid development of CKD. Furthermore, mice had more profound inflammation with highly elevated levels of MCP-1 and CXCL10, produced in part by damaged proximal tubules. Our study directly links low nephron endowment with postnatal renal hypertrophy, which in this model is maladaptive and results in CKD. Underdeveloped kidneys are more susceptible to gentamicin-induced AKI, suggesting that AKI in the setting of low nephron number is more severe and further increases the risk of CKD in this vulnerable population.

Authors

Pamela I. Good, Ling Li, Holly A. Hurst, Ileana Serrano Herrera, Katherine Xu, Meenakshi Rao, David A. Bateman, Qais Al-Awqati, Vivette D. D’Agati, Frank Costantini, Fangming Lin

×

Figure 6

Neonatal RetUB del mice have incomplete renal repair after gentamicin-induced AKI.

Options: View larger image (or click on image) Download as PowerPoint
Neonatal RetUB del mice have incomplete renal repair after gentamicin-in...
Newborn mice (control and RetUB del) were injected with saline or gentamicin once a day for 7 days from P3 to P9. Kidneys were analyzed 1 day (P10) or 1 month after completing treatment. (A) Expression of phospho-histone H3 (pH3, red) in the proximal tubules labeled with LTA (green) in mice 1 day after completion of injections (200× magnification) (B) While saline-injected control and RetUB del mice show no difference in the baseline expression of pH3+ proliferating cells in the renal cortex and outer medulla, gentamicin injury induces a significant increase in the expression of pH3 in control mice (1-way ANOVA followed by Tukey’s test for multiple comparisons, *P = 0.015, n = 4–5 per group) but not in RetUB del kidneys (P = 0.28, n = 5 per group). Comparison of gentamicin-injected control and RetUB del kidneys also shows a significantly lower number of pH3+ cells in the cortex and outer medulla of RetUB del mice compared with controls (**P = 0.0377, n = 5 per group). (C) At 1 month following completion of gentamicin injections, control mice have near complete tubular repair, whereas RetUB del kidneys have areas of tubular atrophy (arrow), interstitial fibrosis, chronic inflammation, and residual tubular vacuolization (arrowhead). (D) Control mice had no significant increase in injury score 1 month after gentamicin injection (1-way ANOVA followed by Tukey’s test for multiple comparisons, P = 0.77, n = 4–5 per group), whereas RetUB del mice had significantly elevated injury scores following gentamicin-induced AKI (*P < 0.01, n = 5 per group, 1-way ANOVA followed by Tukey’s test for multiple comparisons). The difference between injury scores in control and RetUB del mice 1 month after gentamicin-induced AKI were also significant (**P < 0.01, n = 5 per group, 1-way ANOVA followed by Tukey’s test for multiple comparisons). Gent, gentamicin.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts